PUBLIC CONTRACT · 2019
Aquisição de “TRASTUzumab emtansina 160mg po conc sol inj fr iv (P259-2018-214)”
- Contract value
- €94,555.65
- Signed on
- 16 January 2019
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 5692629PUBLISHED DESCRIPTION
07/00150.11/2019 - Aquisição de “TRASTUzumab emtansina 160mg po conc sol inj fr iv (P259-2018-214)”
Parties involved
- Place of performance
- Portugal, Aveiro, Santa Maria da Feira
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- ROCHE FARMACÊUTICA QUIMICA, LDA. · Tax ID 500233810
Values and timeline
- Contract price
- €94,555.65
- Procedure base price
- €94,555.65
- Total effective price
- Not reported on Portal BASE
- Publication date
- 10 July 2019
- Award date
- 21 December 2018
- Signing date
- 16 January 2019
- Performance period
- 365 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Preço ou custo
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2017/6 - Acordo Quadro para fornecimento de Medicamentos do Foro Oncológico e Imunomoduladores, às Instituições e Serviços do Serviço Nacional de Saúde
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 4098286
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.